Verona pharma announces november 2021 investor conference participation

London and raleigh, n.c., nov. 01, 2021 (globe newswire) -- verona pharma plc (nasdaq: vrna) (“verona pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that david zaccardelli, pharm. d., president and chief executive officer, will present at the following investor conferences in november 2021:

VRNA Ratings Summary

VRNA Quant Ranking